SARAH QUNEIBI: Open Payments
NPI 1578126942 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 47 payments from 16 companies in 2025. Trend: 2023 $787 · 2024 $1,132 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $139 |
| Novo Nordisk Inc | 5 | $105 |
| PFIZER INC. | 6 | $104 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| ABBVIE INC. | 4 | $90 |
| Exact Sciences Corporation | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: Veozah, Kerendia, Cologuard Collection Kit, Ozempic, TRELEGY ELLIPTA, VRAYLAR, CAPVAXIVE, ELIQUIS.
Industry payments across FL — which companies pay providers there.
